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Abstract
Background: The foamy virus (FV) replication cycle displays several unique features, which set them apart from 
orthoretroviruses. First, like other B/D type orthoretroviruses, FV capsids preassemble at the centrosome, but more 
similar to hepadnaviruses, FV budding is strictly dependent on cognate viral glycoprotein coexpression. Second, the 
unusually broad host range of FV is thought to be due to use of a very common entry receptor present on host cell 
plasma membranes, because all cell lines tested in vitro so far are permissive.
Results: In order to take advantage of modern fluorescent microscopy techniques to study FV replication, we have 
created FV Gag proteins bearing a variety of protein tags and evaluated these for their ability to support various steps 
of FV replication. Addition of even small N-terminal HA-tags to FV Gag severely impaired FV particle release. For 
example, release was completely abrogated by an N-terminal autofluorescent protein (AFP) fusion, despite apparently 
normal intracellular capsid assembly. In contrast, C-terminal Gag-tags had only minor effects on particle assembly, 
egress and particle morphogenesis. The infectivity of C-terminal capsid-tagged FV vector particles was reduced up to 
100-fold in comparison to wild type; however, infectivity was rescued by coexpression of wild type Gag and assembly 
of mixed particles. Specific dose-dependent binding of fluorescent FV particles to target cells was demonstrated in an 
Env-dependent manner, but not binding to target cell-extracted- or synthetic- lipids. Screening of target cells of 
various origins resulted in the identification of two cell lines, a human erythroid precursor- and a zebrafish- cell line, 
resistant to FV Env-mediated FV- and HIV-vector transduction.
Conclusions: We have established functional, autofluorescent foamy viral particles as a valuable new tool to study FV - 
host cell interactions using modern fluorescent imaging techniques. Furthermore, we succeeded for the first time in 
identifying two cell lines resistant to Prototype Foamy Virus Env-mediated gene transfer. Interestingly, both cell lines 
still displayed FV Env-dependent attachment of fluorescent retroviral particles, implying a post-binding block 
potentially due to lack of putative FV entry cofactors. These cell lines might ultimately lead to the identification of the 
currently unknown ubiquitous cellular entry receptor(s) of FVs.
Background
Spumaviruses, also known as foamy viruses (FVs), repre-
sent the only genus of the retroviral subfamily spumaret-
rovirinae, and resemble complex retroviruses with
respect to their genome structure. The FV replication
strategy deviates in many aspects from that of orthoretro-
viruses [reviewed in [1]]. Interestingly, many of the
unique features of FVs are more reminiscent of another
family of reverse transcribing viruses, the hepadnaviridae
[reviewed in [2]]. This includes the expression of Pol as a
separate protein, instead of the Gag-Pol fusion proteins
typical of orthoretroviruses [reviewed in [3]]. As a conse-
quence, FVs have a specific strategy to ensure Pol particle
incorporation, essential for generation of infectious viri-
ons. Both Gag and Pol proteins of FVs bind to full-length
genomic viral transcripts. Additionally, protein-protein
interactions between Gag and Pol seem to be involved in
this assembly process [4-6]. Other aspects of FV assembly
are also unique among retroviruses; for example, while
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Page 2 of 17FV Gag can preassemble by itself into capsid structures at
the cellular microtubule-organizing-center (MTOC) like
B/D type orthoretroviruses, it apparently lacks mem-
brane-targeting signals. Therefore, such particles are not
released from the cell as virus-like-particles as observed
for other retroviruses [reviewed in [3]]. Similar to Hepati-
tis B virus (HBV), FV particle budding and release are
instead dependent on co-expression of the cognate viral
envelope (Env) protein; moreover, this function of FV Env
that cannot be complemented by expression of heterolo-
gous viral glycoproteins [reviewed in [7]]. A specific
interaction between the cytoplasmic N-terminus of the
FV Env glycoprotein, involving the leader peptide (LP)
and a conserved W10XXW13 motif, and the N-terminal
region of the FV Gag protein, is essential for particle
egress. FV Env-independent capsid release can be
achieved experimentally by artificial N-terminal fusion of
heterologous membrane-targeting signals to the FV Gag.
However, these VLPs are non-infectious even when co-
expressed with the cognate viral glycoprotein [8-10].
Finally, the structural organization of the FV Gag protein
deviates significantly from orthoretroviruses. Unlike
orthoretroviral Gag proteins, FV Gag is not processed
into separate matrix (MA), capsid (CA) and nucleocapsid
(NC) subunits. In fact, only a limited proteolysis is
observed during FV particle morphogenesis, resulting in
the removal of a C-terminal 3 kD peptide. Both the
uncleaved precursor p71Gag and the larger p68Gag cleavage
product are incorporated into the FV capsid, where they
are found in ratios of 1:1 to 1:4 in released infectious viral
particles [11]. Although the FV Gag protein harbors
many functional motifs described for other retroviruses
(such as an PSAP late assembly (L)-domain, a cytoplas-
mic targeting and retention signal (CTRS) to mediate
assembly at the MTOC, a coiled-coil domain essential for
assembly, and a YXXLDL motive important for capsid
morphology and reverse transcription), other motifs are
either missing from FV Gag or if present, are unique
amongst retroviruses [8,12-15]. This includes the lack of
C-terminal Cys-His boxes in Gag implicated in retroviral
RNA packaging [reviewed in [3]]. Instead up to three gly-
cine-arginine-rich sequences (GR-boxes) are found in the
C-terminal region of FV Gag. GR-I was reported to bind
to nucleic acids and was originally implicated in RNA
binding, but this was recently challenged and another
function as an interaction motif for the Gag-Pol interac-
tion during Pol particle incorporation was described
[4,16]. GR-II harbors a nuclear localization signal
sequence responsible for predominant nuclear targeting
of FV Gag at certain time points during viral replication
[16,17]. Furthermore, recently a chromatin-binding site
(CBS) within GR-II was identified mediating attachment
of FV Gag to host chromosomes [18].
In recent years, the combination of fluorescently
labeled virions with modern imaging techniques has
proven to be a powerful tool to study replication in a vari-
ety of viral systems. These methods have been particu-
larly useful for dissecting assembly and entry pathways
[reviewed in [19]]. With respect to retroviruses, single
virus tracking has revealed that Murine Leukemia Virus
(MLV) infection induces establishment of filopodial
bridges that enable efficient cell-to-cell transmission; has
allowed the quantitation of individual HIV particle gene-
sis in real time; and enabled detailed analysis of the very
earliest events during HIV attachment to target cells [20-
22].
Further analysis of the FV replication strategy would
profit greatly from the availability of functional fluores-
cent FV particles. For example, the exact cellular location
of FV Gag - Env interaction could be determined and
examined by time-lapse microscopy. Originally it was
thought to occur at the membrane of the endoplasmic
reticulum, since FV Env contains an ER retrieval signal
and budding seemed to occur at intracellular membranes,
which are believed to be the ER. However, Yu et al.
reported recently a significant Gag - Env co-localization
only in compartments containing Golgi-specific marker
proteins, in a study using FV infected fibroblasts and
immunostaining of fixed samples [23]. Similarly, the cel-
lular location of the Gag - Pol interaction is currently
unknown, and its identification would contribute to the
understanding of FV Pol particle incorporation mecha-
nism. Furthermore, very little is known about the sequen-
tial events leading to FV entry of target cells, and live
imaging of FV uptake could lead to insights into the entry
mechanism of these unusual retroviruses.
Currently, it is thought that FV particles bind to a ubiq-
uitous, but as yet unidentified, cellular receptor. This is
based largely on the observation that FVs are unique
amongst retroviruses in having an extremely broad host
range [24,25]. FV vectors can transduce even bird or rep-
tile cells. Indeed, a species or cell type that is completely
resistant to FV Env-mediated transduction has not been
reported. After attachment, FV capsids apparently are
endocytosed, gaining access to the cytoplasm by a FV
Env-mediated pH-dependent fusion process, and seem to
migrate to the centrosome by piggybacking on dynein/
dynactin motor complexes [26,27]. There they can reside
for long periods of time until disassembling and progress-
ing towards nuclear entry of the FV preintegration com-
plex, induced by yet uncharacterized cellular signals [28].
A few previous studies have employed enhanced green
fluorescent protein (EGFP) tagged FV Gag proteins for
cellular assays [9,18,26]. Petit et al. [26] and Tobaly-Tapi-
ero et al. [18] used different, transiently-expressed N-ter-
minal tagged Gag proteins to characterize the
centrosome-targeting and chromatin-binding motifs in
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uitination on retroviral budding was examined by Zhad-
ina et al. [9] using artificially membrane-targeted, Env-
independently budding PFV Gag protein containing a C-
terminal GFP-tag. However, the functional consequences
of tagging the FV Gag proteins, compared to untagged
wild type FV Gag protein, were not examined in these
studies.
In this study, we systematically analyzed the influence
of different protein tags on PFV Gag's capacity to support
FV replication using recombinant replication-deficient
FV vector particles that are capable of single-round infec-
tions. We succeeded in identifying for the first time auto-
fluorescent protein (AFP)-tagged PFV Gag constructs
that allow generation of fluorescent PFV particles with
nearly wild type functionality; these constructs provide a
powerful tool for analysis of PFV replication steps by
modern imaging techniques. With this tool, a particle-
binding assay for target cells was established. In combina-
tion with high-titer FV Env containing retroviral vector
supernatants, it was used to identify two cell lines that are
resistant to PFV Env-mediated marker gene transfer.
Interestingly, these cells still displayed retroviral particle
attachment in a FV Env-specific manner. Further charac-
terization of the resistance to FV Env-mediated virus
entry in these cell lines might ultimately lead to the dis-
covery of currently unknown cellular molecules essential
for the early stages of FV infection in target cells.
Results
Peptide length and location influence function of tagged 
PFV Gag
We set out to establish a collection of tagged PFV Gag
proteins that retain most of their natural functions essen-
tial for FV replication. With these tools we aim to study
various steps of the FV replication strategy in host cells
by combining different biochemical assays with modern
live-cell imaging techniques. Towards this end we gener-
ated expression constructs containing different protein
tags fused in frame with the PFV Gag ORF (Fig. 1).
Recombinant PFV vector particles containing these Gag
fusion proteins (Gag-FPs) were produced by transient
transfection of 293T cells using a 4-plasmid PFV vector
system [29]. Subsequently, cellular protein expression,
particle-associated protein composition, and infectivity
of recombinant vector particles were examined. Bio-
chemical analysis of cell lysates revealed that all Gag-FPs
were expressed and processed at levels slightly lower or
similar to untagged PFV Gag (Fig. 2A). Increases in the
observed molecular weight of the individual tagged Gag
proteins were consistent with the predicted size of the
different peptide tags added. For N-terminal tagged Gag
proteins, both the p71Gag and p68Gag displayed a higher
mass in comparison to untagged PFV Gag (Fig. 2A, lane
1-6). In contrast, for the C-terminal tagged Gag proteins,
only the p71Gag precursor protein showed a higher molec-
ular weight because normal C-terminal proteolytic pro-
cessing led to authentic p68Gag cleavage products lacking
the tag (Fig. 2A, lane 8-13). Initial analysis of particle
release, by particle concentration through ultracentrifu-
gation and subsequent Western blot analysis using FV
specific antisera, revealed that all of the tagged PFV Gag
proteins appeared to support particle egress (Fig. 2B).
However, in general, the release of capsid containing N-
terminal tagged Gag proteins was significantly decreased
in comparison to wild type (Fig. 2B, lane 1-6). Further-
more, in the lysates of the larger N-terminal AFP-tagged
Gag protein particle preparations no viral glycoprotein
was detectable, evidenced by the lack of PFV Env LP spe-
cific signals (Fig. 2C, lane 3-6). In contrast, particle lysates
of the smaller N-terminal HA-tagged Gag displayed
incorporation of the PFV Env LP subunit (Fig. 2C, lane 2).
To investigate whether detected Gag proteins were par-
ticle-associated or extracellular protein aggregates, puri-
fied particle samples were digested with the membrane-
impermeable protease subtilisin, prior to particle lysis
(Fig. 2B; lower panel). By this treatment, all viral protein
components not enveloped and protected by a lipid
membrane are removed. Indeed, we observed that in all
N-terminal Gag-AFP samples the Gag-specific signals
detected in duplicates that were mock treated (Fig. 2B,
lane 3-6, upper panel) disappeared upon subtilisin diges-
tion (Fig. 2B, lane 3-6; lower panel). All other samples,
including N-terminal HA-tagged- and all C-terminal
tagged Gag proteins, were unaffected by proteolytic
digestion and appear as Gag-specific signals in the West-
ern Blot analysis (Fig. 2B, lanes 1, 2, 7-20; compare upper
Figure 1 Schematic illustration of the PFV Gag (PG) fusion expres-
sion constructs. CMV, cytomegalovirus virus promoter; SD, splice do-
nor; SA, splice acceptor; pA, bovine growth hormone polyadenylation 
signal; L, glycine-serine linker. The p68/p71 PFV Gag cleavage site is 
shown as dashed line. PFV Gag fusion proteins were generated as N- or 
C-terminal fusions. The locations of the different protein tags (HA, 
eGFP, eYFP, mCherry, mCerulean) used are indicated as grey boxes 
(tag). The C-terminal PG CeGFP fusion protein was further modified by 
N-terminal fusion of a membrane-targeting signal (M) (PGM3).
gag 
PG wt      CMV gag 
SD SA 
pA 
1 648 621 
PG Ctag 
NH2 COOH PG Ntag gag L tag 
PGM3-tag M 
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Figure 2 Cellular and particle associated protein expression- and infectivity analysis of PFV Gag-FPs. PFV particles were generated by transient 
transfection of 293T cells using the 4-plasmid PFV vector system. (A-C) Representative Western Blot analysis of 293T cell lysates (cell) (A) and viral par-
ticles (virus) purified by ultracentrifugation through 20% sucrose for N- or C-terminal Gag-FPs (B, C). PFV proteins were detected by using (A, B) a poly-
clonal anti-PFV Gag (α-Gag) or (C) an anti-PFV Env LP (α-LP) specific antiserum. (B) In addition subtilisin- and mock-treated samples were compared 
according to their particle associated Gag expression by α-Gag immunoblot. (D) Relative infectivities of extracellular cell culture supernatants using 
EGFP marker gene transfer assay. The values obtained using wild-type PFV Gag expression plasmids (lane 1, 8) were arbitrarily set to 100%. Mean values 
and standard deviations from three independent experiments are shown. 293T cells were cotransfected with puc2MD9, pcziPol, pczHFVenv EM002 
and either (lane 1, 8) pcoPG4 (wt), (lane 2) pcoPG4 NHA, (lane 3) pcoPG4 NeGFP, (lane 4) pcoPG4 NeYFP, (lane 5) pcoPG4 NCerulean, (lane 6) pcoPG4 
NmCherry, (lane 9) pcoPG4 CHA, (lane 10) pcoPG4 CeGFP, (lane 11) pcoPG4 CeYFP, (lane 12) pcoPG4 CCerulean, (lane 13) pcoPG4 CmCherry or wtGag 
cotransfected at a ratio of 1:1 (lane 14) pcDNA 3.1zeo+, (lane 15) pcoPG4 CHA, (lane 16) pcoPG4 CeGFP, (lane 17) pcoPG4 CeYFP, (lane 18) pcoPG4 
CCerulean, (lane 19) pcoPG4 CmCherry. As control, cells were only transfected with pcDNA3.1 zeo+ (lane 7, 20). (E) Comparison of relative infectivities 
of C-terminal Gag-GFP (Gag-C-GFP) fusion proteins either transfected alone or cotransfected with untagged Gag (wt-Gag) with the EGFP marker gene 
transfer assay, as depicted. The values obtained using wild-type PFV Gag expression plasmids (1:0) were arbitrarily set to 100%. Mean values and stan-
dard deviations from two independent experiments are shown. 293T cells were cotransfected with puc2MD9, pcziPol, pczHFVenv EM002, pcoPG4 
(wt) or/and pcoPG4 CeGFP at different ratios as indicated.
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Page 5 of 17and lower panel). Remarkably, there was an additional
prominent protein band in all C-terminal tagged
mCherry-Gag samples, recognized with both Gag-spe-
cific and mCherry-specific antibodies (Fig. 2A, B, lane 13,
19; data not shown). This protein most probably is the
result of an internal mCherry cleavage, which has been
described in the literature, and is thought to be involved
in maintaining the functional chromophore of this fluo-
rescent protein [30-32].
We further observed that the small HA-tag fused to the
N-terminus of Gag significantly reduced particle release
efficiency in comparison to wild type, which was not
observed for the C-terminal HA-tagged Gag-FP (Fig. 2B,
lane 1, 2, 8, 9). These effects of HA-tag addition on parti-
cle release were in accordance with the calculated relative
infectivities depicted in Fig. 2D. Samples of N-terminal
HA-tagged particles showed a 10-fold reduction of super-
natant-associated infectivity, whereas those of C-terminal
HA-Gag-FP particles were almost at wild type levels (Fig.
2D, bar 1, 2, 8, 9). This suggests that the PFV Gag N-ter-
minus is more sensitive to modifications than the C-ter-
minus. Furthermore, addition of different AFPs to the N-
terminus of Gag almost completely abolished release of
infectious particles (Fig. 2D, bar 3-6). This observation is
in line with the inability of these proteins to support
release of lipid membrane enveloped Gag protein (Fig.
2B, lane 3-6). In contrast, the range of supernatant infec-
tivity measured for C-terminal Gag-AFPs was between 1
- 8% compared to untagged wild type samples (Fig. 2D,
bar 8, 10-13). Since the physical particle release of these
samples was almost equal to wild type (Fig. 2B, lane 8-13),
this reduction in measurable infectivity indicates that a
larger C-terminal fusion tag might interfere with replica-
tion steps other than particle release. No major difference
in the relative incorporation and processing of Pol was
observed in released particles of the individual Gag
mutants (data not shown). To examine if untagged wild
type PFV Gag protein is able to rescue the particle release
and infectivity defects observed for some of the Gag-FP,
we cotransfected expression constructs of both type of
proteins at various ratios (Fig. 2; and data not shown). In
Fig. 2E, the influence of cotransfection of various ratios of
wild type Gag with C-terminal tagged Gag-GFP on super-
natant infectivity is shown. By increasing the ratio of wild
type Gag protein to tagged protein the infectivity could
be restored, reaching wild type levels at a 3:1 ratio of wild
type to tagged Gag protein and 50% infectivity levels at a
1:1 ratio. For the N-terminal tagged Gag-GFP, cotransfec-
tion of wild type Gag was unable to restore supernatant
infectivity to wild type levels, even at a 15-fold excess of
wild type Gag expression construct (data not shown).
This suggests a dominant negative effect of the N-termi-
nal Gag-GFP fusion. Subsequently, physical particle
release of all fusion proteins was analyzed at a 1:1
cotransfection ratio and compared to conditions without
wild type Gag protein coexpression (Fig. 2A-D; and data
not shown). For all C-terminal tagged Gag constructs a
similar ratio of tagged and wild type protein was detected
in corresponding cell and particle lysates (Fig. 2B, lane
14-20). In contrast, no tagged Gag protein was observed
in particle lysates of samples cotransfected with N-termi-
nal AFP-tagged constructs (data not shown). Supernatant
infectivities of the C-terminal tagged constructs were
restored to 15-100% of wild type levels independent of
the specific tag sequence used. The relative differences in
infectivities between the various tagged constructs were
similar, independent of wild type Gag protein coexpres-
sion. Thus, C-terminal, but not N-terminal AFP-tagged
PFV Gag proteins, can interact with wild type Gag pro-
tein to allow release of mixed particles with greatly
improved specific particle infectivity.
C-terminally tagged Gag-AFPs display nearly normal capsid 
structures and budding characteristics
Due to the apparently decreased infectious titer of several
Gag-AFP tagged particles observed, we were interested in
taking a closer look at the particle morphology of these
fluorescent viruses. Therefore, we used ultrastructural
EM (electron microscopy) to analyze 293T cells express-
ing different GFP-tagged Gag-FPs in the context of the 4-
plasmid FV vector system (Fig. 3).
Wild type unmodified Gag proteins were found to
assemble into homogenous spherical capsids accumulat-
ing intracellularly in large amounts mainly at the MTOC
(microtubule organizing center), as previously reported
(Fig. 3A, B). Furthermore, particle budding was observed
into intracellular vesicles and to a large extent also at the
plasma membrane, sometimes associated with capsids
aggregating at the plasma membrane (Fig. 3C, D). Similar
to wild type PFV Gag, N-terminal tagged Gag-GFP also
assembled into capsids with wild type morphology and
accumulating mainly at the MTOC (Fig. 3E, F). However,
in these samples no budding profiles could be detected
(Fig. 3E, F; and data not shown). This is in line with the
biochemical analysis (Fig. 2B, C) and indicate that the
lack of particle release may be due to a failure of the N-
terminal tagged Gag-AFP to successfully interact with
PFV Env, an interaction that is essential for capsid-mem-
brane association. In contrast, C-terminal Gag-GFP-FPs
were found to bud at the plasma membrane, indicating
that a functional Gag-Env interaction occurs and that the
GFP tag does not influence late budding events (Fig. 3J,
K). In this case, capsid morphology seemed to be slightly
more heterogeneous compared to untagged capsids. But
capsids were also found to accumulate at the MTOC, and
budding structures containing the typical prominent FV
Env spike structures at the plasma membrane were
observed (Fig. 3G, I, J, K). Remarkably, in some cells in
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Figure 3 Electron microscopy analysis of transfected 293T cells. Electron micrographs showing representative thin sections of transiently trans-
fected 239T cells using the 4-plasmid vector system. (A-D) Untagged PFV Gag expression construct. Arrowheads point to centrioles (MTOC, microtu-
bule organizing center). The arrowhead points to a budding particle into intracellular vesicles. (E-F) N-terminal Gag-GFP expression construct. (G-K) C-
terminal Gag-GFP expression construct. Magnifications: (A) 18000×, (B) 58000×, (C) 41000×, (D) 117000×, (E) 23000×, (F) 33000×, (G) 47000×, (H) 
20000×, (I) 28000×, (J) 65000×, (K) 71000×. scale bar: 200 nm.
A B C
D
E F
G H I
K
J
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potentially aberrant capsid structures which might repre-
sent sites of protein degradation (Fig. 3H). These curious
structures were neither found at the budding site nor in
released viruses of C-terminal tagged PFV Gag samples
nor in samples of other tagged or wild type Gag con-
structs. This suggests that C-terminal AFP tags to the
PFV Gag protein may result in some minor interference
with intracellular capsid assembly, however, all budding
and released virions displayed wild type morphology.
EYFP and EGFP are the most convenient tags to analyze 
PFV capsids by fluorescence microscope techniques
Since the biochemical analysis revealed that all four C-
terminal tagged autofluorescent Gag-FPs mediate parti-
cle release of infectious virions, we were interested to
determine if single fluorescent particles can be imaged by
Confocal Laser Scanning Microscopy (CLSM). For this
purpose particles purified by ultracentrifugation were
spotted onto glass cover slips, fixed and further analyzed
by CLSM. The results obtained are summarized in Fig. 4.
Whereas EGFP and EYFP tagged PFV particles could be
detected very easily, mCherry and mCerulean modified
virus particles showed very low signal intensities (Fig.
4A). Although mCerulean and mCherry were incorpo-
rated into particles (Fig. 2B, lane 12, 13), they were only
detectable by making "blind scans". Subsequent image
correction with ImageJ plugins and further modifications
of brightness and contrast levels, finally led to the images
shown in Fig. 4B. The particle signal intensities calculated
from non-modified original scan pictures and the results
given as average of the maximum pixel values per particle
(n = 30) are shown in Fig. 4A. Furthermore, no GFP sig-
nals were detected in mock-purified supernatants of
293T cells, which were cotransfected with pcoPG4
CeGFP in the context of the 4-plasmid vector system
lacking an Env expression plasmid (data not shown).
Thus PFV Gag-AFP proteins seem to be released in par-
ticulate forms in a PFV Env-dependent manner, like the
wild type protein.
Gag-GFP labelled PFV particle preparations contain single 
viruses
We were interested in verifying that autofluorescent PFV
particle preparations contain predominantly single viri-
ons and not aggregates. For this purpose a comparative
ultrastructural analysis on C-terminal Gag-GFP-tagged
PFV particle preparations was applied. Labelled virions
were harvested by ultracentrifugation and simultaneously
fixed in paraformaldehyde. Purified PFV particles were
prepared for a combined AFM (atomic force microscopy)
and CLSM analyses, performed as described in materials
and methods. They were mixed prior to analysis with flu-
orescent beads (100 nm in diameter) to obtain topo-
graphical landmarks useful for alignment of AFM and
CLSM scans resulting in three important advantages.
First, the same excitation wavelength (488 nm) could be
used for Gag-GFP labelled virions and fluorescent beads.
Furthermore, CLSM scans nicely show oversaturated
beads located next to less intensive GFP-tagged particles,
a typical example of which is shown in Fig. 5A. Second,
applying distance measurement analysis between beads
Figure 4 CLSM analysis of purified PFV Gag-labelled particles. Vi-
ruses were produced by transfecting 293T cells with expression plas-
mids for Env, Pol, RNA and the appropriate C-terminal tagged Gag-AFP 
and harvested by ultracentrifugation. Subsequently purified virus was 
incubated on glass cover slips, fixed and the samples covered in Mow-
iol. (A) Comparison of fluorescence intensities of background subtract-
ed and smoothed pictures (ImageJ plugins). The mean of at least three 
randomly taken areas of each particle population was determined. Av-
erage and Standard Deviation are depicted. (B) Confocal Laser Scan-
ning Microscopy (CLSM) analysis revealed, that only GFP and YFP 
labelled virus were efficiently detected inside virus capsids. Although 
all four fluorescent Gag fusion proteins are incorporated into released 
particles at comparable amounts (compare with Fig. 2), particles made 
by mCerulean- or mCherry-Gag were only marginally detectable.
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the appropriate GFP-tagged particles in the AFM scan
(Fig. 5B). Third, the bead diameter of 100 nm gave us the
possibility to compare the size of PFV particles in the
AFM scan. In cross section analysis the average height of
single PFV particles was calculated as 85 nm (n = 11,
standard deviation 13 nm; data not shown). Thus com-
bined AFM- and CLSM analysis confirmed that C-termi-
nal AFP-tagged PFV particle preparation contained
predominantly single virions.
PFV particles bind to the host cell surface, but not to 
extracted host cell lipids
One special feature of the FV life cycle is an extremely
broad host range. To date, there are no reports identifying
species, tissues or cell types that are not susceptible to FV
Env-mediated transmission. This suggests that the FV
receptor molecule(s) is evolutionarily well conserved and
present on most if not all eukaryotic cell membranes. We
were interested in using the functional fluorescently-
tagged PFV particles described above as a tool to mea-
sure and visualize potential virus-receptor interactions.
Host cell lipids, in addition to proteins and carbohy-
drates, are the major constituent of cellular membranes
and are also implicated in uptake mediated by VSV-G, a
viral glycoprotein displaying a broad host range similar to
the FV Env protein [33,34]. The potential involvement of
host cell lipids for FV Env mediated entry was tested
using two approaches. First, synthetic lipids or a lipid
mixture extracted from the FV susceptible human cell
line HeLa were spotted onto a glass slide. Subsequently,
several differently tagged viral particle preparations, nor-
malized for physical particle concentration, which was
determined by FCS, were incubated with the spotted lip-
ids. After extensive washing, particle binding was exam-
ined by CLSM (Fig. 6A). GFP-tagged HIV-VSV-G
pseudoparticle binding was detectable for HeLa lipids
containing phosphatidylserine (PS) and to a slightly lower
extent for a mixture containing 30% synthetic PS (DOPS,
dioleoyl phosphatidylserine) and 70% DOPC (dioleoyl
phosphatidylcholine), but not for DOPC alone (Fig.
6A+B, left column). In contrast, both GFP-tagged HIV
virions lacking a viral glycoprotein and GFP-tagged PFV
virions displayed minimal or no binding capacity to any
of the lipids examined (Fig. 6A+B, center and right col-
umn). In a second approach, HeLa cell lipid extracts were
used to generate giant unilamellar vesicles (GUV). Con-
trol experiments showed that these lipid extracts con-
tained both charged lipids as PS and glycosylated lipids as
GM1 (data not shown). But incubation of these GUVs
with purified EGFP-tagged PFV virions for up to 30 min-
utes followed by CLSM analysis of the samples resulted in
no indication of FV particle attachment to the GUV sur-
face (Fig. 6C), whereas HIV-VSV-G pseudotype particle
binding was clearly detectable (data not shown). Labelled
PFV virion signals were only detectable in the liquid sur-
rounding the GUVs (Fig. 6C). Thus, neither lipids
extracted from susceptible cells by the method employed
nor selected synthetic lipids seem to contribute to PFV
particle attachment.
Second, we examined the capacity of fluorescent PFV
particles to bind to target cells. For this purpose HeLa
cells were incubated with concentrated GFP-tagged PFV
virions, followed by extensive washing and subsequent
investigation by CLSM analysis. Binding of Gag-GFP-
labelled particles to the surface of HeLa cells was readily
detectable (Fig. 6D, PGwt +Env). Since particle release of
FVs is strictly glycoprotein-dependent, we were unable to
assess the binding capacity of FV VLP lacking FV Env.
Therefore we made use of a PFV Gag mutant (PGM3)
that contains a heterologous N-terminal membrane-tar-
geting signal to examine the FV Env-independent binding
capacity of FV virions. Similar PFV Gag proteins were
reported previously to enable Env-independent PFV par-
ticle release [8,9]. As illustrated in Fig. 6D GFP tagged
PGM3 virions harboring PFV Env (PGM3 +Env) were
capable of attaching to the HeLa cell surface whereas GFP
tagged PGM3 virions generated in the absence of PFV
Env coexpression (PGM3 ΔEnv) had a strongly reduced
binding capacity. Thus, specific binding of GFP-tagged
virus to target cells was observed.
Figure 5 Comparative analysis of Gag-GFP labelled PFV particles 
by CLSM and AFM. Panel A shows the CLSM image of a 100 nm fluo-
rescent bead (on the left) and a PFV virion (on the right) supported on 
poly-D-lysine coated mica. The high PMT electronic gain necessary to 
detect the signal from the PFV virion resulted in saturation of the pixels 
corresponding to the fluorescent bead. Panel B shows the topograph-
ical AFM image of the same part of the sample shown in panel A.
GFP A 
B 
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Figure 6 CLSM analysis of Gag-GFP labelled virus binding to host cell lipids. (A) Incubation of concentrated PFV, VSV-G pseudotyped HIV parti-
cles and HIV VLPs (ΔEnv) with extracted HeLa lipids or synthetic lipids (DOPC/DOPS, DOPC). On DOPC (Dioleoyl phosphatidylcholine), a synthetic neu-
tral phospholipid, none of the particles bound. The mixture containing 30% negatively charged DOPS (Dioleoyl phosphatidylserine), which is 
necessary to mediate VSV-G particle binding, interacted with HIV VSV-G pseudoparticles. Binding to extracted lipids from HeLa cells (Hela lipids) was 
only detectable for HIV VSV-G pseudoparticles. Scale bars: 5 μm. (B) The total amount of particles bound to the lipid surface was quantified by auto-
mated image analysis (average of 3 scanned areas and 3 scans each). (C) Concentrated Gag-GFP labelled PFV particles (grey channel) were incubated 
with GUVs (Giant Unilamellar Vesicles, red channel), prepared from HeLa lipids and the a far-red lipid dye DiD-C18. No particle binding to the lipid 
membrane was observed. Images of the same GUV at two different time points (0s, 8s) are shown. Scale bar: 5 μm. (D) Binding of GFP labelled wt 
(PGwt) or PGM3 derived (PGM3) PFV particles containing (+Env) or lacking (ΔEnv) PFV Env (grey channel, upper panel) to the cell surface of HeLa cells. 
Nuclei were stained with DAPI (blue channel). The corresponding DIC images are shown below.
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cytometric assay to assess target cell binding of GFP-
tagged PFV virions was established. A clear shift in the
mean fluorescence intensities was observed upon incuba-
tion of HeLa cells with wild type Gag-GFP-labelled parti-
cles (PG-GFP) in comparison to mock treated cells
(mock) (Fig. 7A). Further this shift was also obtained for
PGM3-GFP labelled particles harboring PFV Env
(PGM3-GFP +Env) in comparison to those lacking PFV
Env (PGM3-GFP ΔEnv) or mock-treated cells (mock)
(Fig. 7B). However, a significant binding activity of Env-
deficient PGM3-GFP particles (PGM3-GFP ΔEnv) was
detected on HeLa cells in comparison to mock-incubated
cells (mock), implying an Env-independent component of
FV particle attachment to target cells similar to previous
reports for other retroviruses [35]. Target cell attachment
of Gag-GFP labelled PFV virions was dose-dependent
(Fig. 7C) and could be competed for by untagged PFV
particles (Fig. 7D).
Identification of cell lines resistant to PFV-Env mediated 
vector transduction
Previous attempts to identify cell lines non-permissive for
FV infection proved to be unsuccessful [24,25]. We
extended the analysis of FV-Env mediated host range fur-
ther by challenging target cells of various origins with
high-titer supernatants of PFV vectors and HIV-1 VSV-G
or PFV Env pseudotypes (Fig. 8A, B). First, we examined
whether proteoglycans are essential for PFV transduction
by comparing the transduction efficiency of mouse L-cell
and a proteoglycan synthesis-deficient subclone thereof
called Sog9 [36]. As shown in Fig. 8A, Sog9 cells were 2-3
fold better transduced by HIV-1 VSV-G pseudotypes
Figure 7 FACS analysis of PFV particle binding to HeLa cells. (A, B) Histogram data of measured GFP signal intensities obtained after incubation 
of (A) GFP-tagged wt (PG-GFP) or (B) PGM3 derived (PGM3-GFP) PFV particles, containing (+Env) or lacking (ΔEnv) PFV Env, with HeLa cells. (C) Target 
cell attachment of Gag-GFP labelled PFV virions was dose-dependent. (D) GFP-tagged particle binding could be competed for by preincubation with 
untagged PFV particles. HeLa cells were preincubated with untagged PFV particles at different concentrations. After preincubation with untagged 
PFV particles, the virus-containing solution was replaced by GFP-tagged viruses at equal amounts in each sample.
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Page 11 of 17than parental mouse L cells. In contrast, PFV Env-medi-
ated transduction of PFV or HIV-1 PFV Env pseudotypes
was diminished about 10-fold on the Sog9 cell line in
comparison to parental mouse L cells; nevertheless Sog9
cells were still clearly susceptible to PFV Env-mediated
entry. This indicates that proteoglycans are not absolutely
essential for FV susceptibility, although they seem to con-
tribute to significant extent to PFV Env-mediated infec-
tion efficiency. Second, we examined transduction
efficiencies of various other target cells including cells of
the human hematopoietic lineage and other species (Fig.
8A, B; and data not shown). All target cell types examined
were clearly susceptible to VSV-G mediated marker gene
transfer (Fig. 8A, B; and data not shown). However, the
extensive analysis led to the identification of two cell lines
apparently resistant to PFV Env-mediated vector trans-
duction (Fig. 8A, B). No infectivity of PFV Env containing
vector supernatants was detectable on the zebrafish cell
line Pac2 (Fig. 8A) and the human erythroid precursor
cell line G1E-ER4 (Fig. 8B) even after transduction by spi-
noculation. In contrast, VSV-G pseudotype titers were
500-fold above the detection limit.
Finally, we examined these two cell lines, along with
susceptible adherent and suspension cell lines as controls,
for their retroviral particle binding capacity. Therefore
the flow cytometric assay using various GFP-tagged ret-
Figure 8 Host cell characteristics of PFV Env-mediated transduction and Gag-GFP particle binding. (A, B) Evaluation of different retroviral vec-
tor titers on various adherent- (A) or suspension (B) cell lines. mock: non-infected cells; PFV: PFV vector transduced; HIV-PFV: HIV - PFV Env pseudotype 
transduced; HIV-VSV-G: HIV - VSV-G pseudotype transduced. (C, D) Comparison of mean EGFP fluorescence signals of various adherent- (C) or suspen-
sion (D) cell lines after incubation with different Gag-GFP-tagged retroviral particles. Mock: PBS incubated; PFV PGwt +Env: PFV Env containing C-GFP-
tagged PFV Gag wt particles; PFV PGM3 ΔEnv: Env-deficient C-GFP-tagged PFV Gag PGM3 particles; PFV PGM3 +Env: Env containing C-GFP-tagged 
PFV Gag PGM3 particles; HIV ΔEnv: Env-deficient GFP-tagged HIV VLPs; HIV PFV: PFV Env pseudotyped HIV VLPs; HIV-VSV-G: VSV-G pseudotyped HIV 
VLPs.
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Page 12 of 17roviral virions as described above was used to get a first
idea at which step of the entry process the block might
occur (Fig. 8C, D). Most adherent and suspension cell
lines examined clearly bound VSV-G containing HIV
particles, in line with the transduction data (Fig. 8C, D),
although significant cell-type specific differences in rela-
tive binding capacities of corresponding Env-less or Env-
containing particles were observable. Binding of FV Env
containing particles but not of VSV-G pseudotypes was
diminished on the proteoglycan synthesis deficient Sog9
cells in comparison to the parental mouse L-cells (Fig.
8C). This is in line with the transduction susceptibility
data of these cell lines. Interestingly, Pac2 cells still specif-
ically bound different FV Env containing PFV particles
(Fig. 8C). The same was observed for G1E-ER4 cells;
however, here clearly specific binding of FV Env-contain-
ing virus was only observable by using spinoculation
(spin) during particle incubation with the target cells (Fig.
8D). Taken together, these data suggest that both cell
lines still demonstrate a FV Env specific attachment of
retroviral particles, and a currently unknown post-attach-
ment block might be responsible for the failure of FV
Env-mediated marker gene transfer and expression by
different retroviral vectors in these target cells.
Discussion
Addition of peptide tags to proteins can interfere with
their natural function, often in a position- and size-
dependent fashion. In particular, if no high-resolution
structural information on the protein of interest is avail-
able, as is the case for the FV Gag protein, a careful func-
tional characterization of the fusion protein in
comparison to its wild type counterpart is necessary to
allow its further use to address specific scientific ques-
tions. Here, we added various tags at different positions
of the PFV Gag protein and examined their effects on
biological function in comparison to the unmodified wild
type protein. In general we observed that a small HA-tag
had no or only minor effects in contrast to the more
severe consequences of larger AFP tags. Furthermore,
fusions to the N-terminus of PFV Gag were more detri-
mental than C-terminal fusions.
Whereas no major difference in capsid assembly and
morphology could be observed for N-terminal tagged
PFV Gag proteins by ultrastructural analysis, the small
HA-tag significantly decreased particle export; export
was reduced even more drastically, to undetectable levels,
when the larger AFP tags were used. This is consistent
with the current view, that the N-terminal part of FV Gag
is involved in a specific interaction with the cognate Env
protein that is essential for budding and particle release
[10,14,37]. Larger tags may lead to a stronger steric inter-
ference than smaller ones. In line with these data, the
sensitivity of the FV Gag N-terminus towards modifica-
tions has been reported previously for Env-independently
budding Gag variants containing N-terminal replacement
or additions of heterologous membrane (M) targeting sig-
nals [8,9]. When examined these particles were non-
infectious even upon FV Env coexpression. Similarly, the
PGM3 mutant used in this study was non-infectious as
well (data not shown). Furthermore, a detailed mutagene-
sis and replacement analysis of the N-terminal 11 aa of
PFV Gag by Life et al. [10] revealed that M signal replace-
ment abolishes infectivity to undetectable levels and leads
to gross morphological defects. Pelletable mutant Gag
particles contained little genomic RNA and deviated in
density from wild type. Similarly, we observed release of
small extracellular amounts of N-terminal AFP-tagged
Gag but no measurable infectivity. Although pelleted like
viral particles, they were not protected against proteolytic
digestion by subtilisin. This strongly suggests for these
mutants a release of AFP-Gag aggregates rather than reg-
ular VLPs, which is further supported by the nearly unde-
tectable Env subunit levels in these particle lysate
samples.
FV capsids have been reported to accumulate near the
centrosome initially during virus entry, but later on also
upon particle assembly [8,23,26,38], suggesting that
microtubule-dependent transport processes are involved
for both steps of the FV replication cycle. The study by
Petit et al. [26] investigating FV entry processes utilized
N-terminal GFP-tagged PFV Gag proteins and identified
an interaction with dynein light chain 8 (LC8) as an
essential step for MTOC targeting of incoming particles.
However, rather than producing GFP-tagged FV particles
and examining their uptake into target cells, the authors
transfected N-terminal GFP-tagged PFV Gag expression
constructs. This, of course, means that they were analyz-
ing de novo Gag expression, particle assembly and egress,
and not entry processes. This raises the question,
whether the identified LC8 interaction is indeed involved
in FV entry. It may be that it is important for both types
of transport processes; however, this needs to be carefully
evaluated. Our data clearly indicate that N-terminal Gag-
AFPs show a block in PFV particle egress after capsid
assembly and accumulation at the centrosome, and are
not suited for analysis of FV entry processes.
In contrast, particle release supported by C-terminal
tagged PFV Gag proteins was similar to wild type. Differ-
ences (12 to 100-fold) in the relative infectivities of the
fluorescent particles were observed, independent of the
AFP tag used. However, this did not appear to correlate
with differences in particle egress. Currently, the cause of
these differences is unclear. However, the diminished rel-
ative infectivity observed is reminiscent of reports of
other retroviral Gag-AFP fusion proteins [39,40]. Elec-
tron microscopic ultrastructural analysis of C-terminal
AFP-tagged FV capsids revealed that this effect is not due
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orthoretroviral Gag harboring a C-terminal AFP tag [41].
This suggests that pure Gag-GFP containing FV particles
might have defects in disassembly, leading to the
observed decrease in infectivity observed in the marker
gene transfer assays. The exact cause remains to be char-
acterized.
C-terminal GFP-tagged particles were used further to
study the virus - target cell interaction. We demonstrated
that selected synthetic lipids, as well as lipids extracted
from susceptible target cells, do not contribute to virus
adsorption or attachment as previously reported for ret-
roviral VSV-G pseudotypes [34]. In contrast, we showed
that fluorescent FV particles bind specifically to target
cells. Since FVs naturally are unable to release VLPs with-
out Env, we verified binding specificity by using a non-
infectious Env-independent budding Gag mutant
(PGM3). For this mutant equal amounts of Gag-driven
particle release were observed independently of PFV Env
coexpression. Env containing PGM3 particles showed
specific binding to target cells in CLSM analysis and were
more quantitative in a flow cytometric binding assay. In
combination with a screen of various target cell types for
susceptibility to transduction by high titer retroviral vec-
tor supernatants, this binding assay was used to charac-
terize features of FV attachment to target cells. First,
using mouse L cells, and a glycosaminoglycan synthesis
deficient subclone (sog9) thereof, we found that gly-
cosaminoglycans contribute to FV attachment and trans-
duction. However, they are not essential for FV Env-
mediated particle binding and entry and therefore seem
not to represent the currently unknown but ubiquitous
cellular receptor of FVs. More importantly, for the first
time two cell lines were identified that are resistant to FV
Env-aided gene transfer. The human erythroid precursor
cell line G1E-ER4 and the zebrafish cell line Pac-2 were
both resistant to transduction by FV Env-containing
high-titer retroviral vectors. Transduction resistance cor-
related with the FV Env protein and not the nature (FV
vs. HIV) of the enveloped capsid structure. However, for
both cell lines, specific binding of fluorescent FV Env-
containing retroviral particles to the cell surface was
observed, although spinoculation had to be used for the
G1E-ER4 suspension cells. Taken together these trans-
duction and binding data suggest that FV Env-containing
particles can still attach to these target cells, maybe by
low-affinity scaffold interactions involving cell surface
proteoglycans, for example. However, viral- and cellular
lipid membrane fusion and release of the capsid into the
cytoplasm of these cells are apparently blocked, poten-
tially because this process in FV entry is dependent on a
specific cellular molecule lacking in these cells. A detailed
comparison of the entry processes in susceptible cells and
these non-permissive target cells is required to confirm
or reject this hypothesis.
Conclusions
In summary, this study precisely describes for the first
time the development of functional, fluorescent FV parti-
cles, opening up a new field in Foamy virus research.
Moreover, the identification of the non-permissive G1E-
ER4 and Pac-2 cells will allow further insight into various
steps of the FV replication cycle, in particular concerning
virus entry and potentially identification of its currently
unknown ubiquitous cellular receptor.
Methods
Cells
The human kidney cell line 293T [42], the human fibro-
sarcoma cell line HT1080 [43], the mouse L, the sog9 [36]
and the HeLa cell line [44] were cultivated in Dulbecco's
modified Eagle's medium supplemented with 10% heat-
inactivated fetal calf serum and antibiotics. HeLa cells
were cultivated in phenol red free media. The zebrafish
embryonic fibroblast cell line Pac2 was cultivated in Lei-
bovitz media L15 supplemented with 20% heat-inacti-
vated fetal bovine serum and antibiotics at 28°C [45,46].
The suspension T-cell line Jurkat [47] was cultivated in
RPMI-1640 media supplemented with 10% heat-inacti-
vated fetal calf serum and antibiotics. The immortalized,
erythroid suspension cell line G1E-ER4 was cultivated in
Iscove's modified Dulbecco's medium, supplemented
with 15% heat-inactivated fetal calf serum, recombinant
human erythropoietin (2 U/ml) and recombinant rat SCF
(50 ng/ml) [48].
Expression constructs
The original 4-plasmid PFV vector system consisting of
the PFV Gag expression vector pcziPG4, the PFV Pol
expression vector pcziPol, the PFV Env expression con-
struct pczHFVenvEM002, and the enhanced green fluo-
rescent protein (EGFP)-expressing PFV transfer vector
pMD9, has been described previously [29]. In this study
an expression-optimized PFV Gag construct pcoPG4
(PG) was used instead of the original pcziGag4 construct
that contains the wild type PFV Gag ORF. Expression-
optimization and gene synthesis was done by Geneart,
Regensburg, Germany. Furthermore, a variant transfer
vector puc2MD9 was used, containing a pUC19 back-
bone with a SV40 ori instead of the pcDNA3.1 zeo back-
bone of the original pMD9 vector. For some experiments
the PFV transfer vector pMD11, encoding lacZ as
reporter gene, was used [29]. A schematic outline of the
PFV Gag constructs used in this study is shown in Fig. 1.
Expression vectors for Gag fusion proteins were cloned
by fusing the tag sequence (HA, EGFP, EYFP, mCerulean
or mCherry), together with a flexible glycine-serine (G/S)
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terminal (e.g. pcoPG4 CeGFP) to the PFV Gag ORF in
pcoPG4. Further modification of pcoPG4 CeGFP by addi-
tion of an N-terminal tag comprising the c-src mem-
brane-targeting signal (aa 1-10), a HA tag, a flexible G/S
linker and an additional N-terminal Gag p68/p3 prote-
olytic cleavage site to the full-length PFV Gag ORF
resulted in the generation of the PGM3 mutant, allowing
PFV Env-independent membrane-targeting (Linde-
mann, unpublished data). All Gag fusion protein (FP)
expression constructs were generated using standard
PCR cloning techniques and mutagenesis primers and
were verified by sequencing analysis. Details are available
upon request. In some transduction experiments a repli-
cation-deficient lentiviral vector system was used. HIV-1
pseudotyped viruses were generated by cotransfection of
the constitutively EGFP expressing lentiviral transfer vec-
tor p6NST90 (Lindemann, unpublished) and the packag-
ing plasmids pCD/NL-BH and pczVSV-G encoding for
HIV-1 Gag/Pol and the VSV-G protein (Vesicular Stoma-
titis Virus glycoprotein G), respectively [49,50].
Generation of viral supernatants and analysis of 
transduction efficiency
FV supernatants containing recombinant viral particles
were generated essentially as described previously
[51,52]. Briefly, FV supernatants were produced by
cotransfection of 293T cells with transfer vector
(puc2MD9 or pMD11), Env- (pczHFVenvEM002), Pol -
(pcziPol), and Gag packaging plasmid (pcoPG4 or PG
mutants thereof as indicated) at a ratio of 4:4:4:1 using
polyethyleneimine (PEI) or Polyfect transfection
reagents. At 24 h posttransfection, sodium butyrate (final
concentration, 10 mM) was added to the growth medium
for 8 h. Subsequently, the medium was replaced, and viral
supernatants were harvested an additional 16 h later.
Lentiviral supernatants were generated by cotransfection
of transfer vector (p6NST90), Gag/Pol packaging plasmid
(pCD/NL-BH), and an Env packaging plasmid (pczVSV-
G or pczPE01) at a ratio of 1:1:1 and harvested as
described above.
Transductions of recombinant EGFP expressing PFV
vector particles containing various PFV Gag proteins
were performed by infection of 2 × 104 HT1080 cells,
plated 24 h in advance in 12-well plates. For the infection
1 ml of the viral supernatant or dilutions thereof were
incubated with the target cells for 4 to 6 h. The percent-
age of EGFP-positive cells was determined by fluores-
cence-activated cell sorter (FACS) analysis 72 h after
infection. All transduction experiments were performed
three times, and in each independent experiment the val-
ues obtained with the wild-type construct pcoPG4 were
arbitrarily set to 100%. Analysis of tissue tropism of dif-
ferent PFV vector particles or HIV-1 vector pseudotypes
was performed on various target cell lines. Adherent tar-
get cells (HT1080, HeLa, mouseL, Sog9, Pac2), which
were plated one day in advance at a density of 2 × 104 cells
in 12-well plates, were infected with one ml of viral cell
culture supernatant or dilutions thereof. Target cells
growing in suspension (Jurkat, G1E-ER4) were infected
by resuspending 1 × 105 target cells in one ml of viral cell
culture supernatant or dilutions thereof. Afterwards they
were transferred into a 6-well plate and either incubated
at 37°C, 5% CO2 in a humidified incubator or centrifuged
for 1 h at 2000 rpm (30°C) before the incubation step. Six-
teen hours later the viral cell culture supernatant was
replaced for both types of target cells by fresh media and
the transduction efficiency was determined by flow
cytometry 72 - 96 h after infection as described above.
Biochemical analysis of PFV particles
Biochemical analysis of purified PFV particles was essen-
tially performed as described previously [15,53]. Briefly,
the cell-free viral supernatant, generated by transient
transfection of 293T cells as described above, was har-
vested by sterile filtration (pore size, 0.45 μm) and centri-
fuged at 4°C and 25,000 rpm for 3 h in an SW40 or SW28
rotor through a 20% sucrose cushion. The supernatant
was discarded, and the viral pellet was gently resus-
pended in 50 μl phosphate-buffered saline (PBS). An
equal volume of 2× sodium dodecyl sulfate (SDS) protein
sample buffer (2×PPPC) was added to the samples, which
were separated by SDS-polyacrylamide gel electrophore-
sis (PAGE) and analyzed by Western Blotting as
described below. In some experiments viral particles were
resuspended in a larger volume (134 μl PBS). Subse-
quently, 67 μl of each sample were proteolytically
digested with subtilisin (0.5 mg/ml), the other part was
incubated with PBS instead, for 2 h at 37°C. Digestion was
terminated by addition of 2 μl phenylmethylsulfonyl fluo-
ride (20 mg/ml) and 6×PPPC.
Antisera, Western blot expression analysis
Western blot expression analysis of cell- and particle-
associated viral proteins was performed essentially as
described previously [53]. Polyclonal antisera used were
specific for PFV Gag [54] or the LP of PFV Env, aa 1 to 86
[53]. The chemiluminescence signal was digitally
recorded using a LAS-3000 imager.
FACS based analysis of viral particle target cell binding
A flow cytometric assay was applied to determine and
compare the capability of individual particle preparations
to specifically bind to selected target cells. GFP-tagged
PFV PG or PFV PGM3 derived particles of 10 ml viral
supernatant, generated by transient transfection of 293T
cells as described above, were harvested, concentrated by
ultracentrifugation and resuspended in 100 μl PBS (phos-
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calf serum. HIV VSV-G pseudoparticles were generated
as described previously [40]. Adherent target cells were
detached with PBS-EDTA. Subsequently, 5 × 104 cells
were incubated with virus or dilutions thereof in a total
volume of 100 μl. After 30 min incubation on ice, cells
were washed two times with FACS buffer (phosphate
buffered saline, 1% inactivated fetal calf serum). For the
competition experiment, untagged PFV particles or dilu-
tions thereof were incubated 30 min on ice, washed two
times with FACS buffer and subsequently incubated
another 30 min with GFP-tagged PFV particles. After a
fixation step with 6% formaldehyde, the cell pellets were
resuspended in 150 μl FACS buffer, stored on ice, and
analyzed by flow cytometry using a FACS Calibur (Bec-
ton Dickinson). The mean fluorescence of 8,000 - 10,000
events per sample was subsequently determined using
the Cell Quest software package (Becton Dickinson).
Lipid binding assays
Lipid binding assays were performed with purified PFV
particles or HIV pseudoparticles, generated as described
above. Synthetic lipids were obtained from Avanti Polar
Lipids, Alabaster, USA. Lipid extracts were prepared
from non-transfected HeLaP4 cells according to Dreyfus
et al. [55]. This is a modified method according to Folch-
Pi et al. with optimizations for recovering highly polar
lipids like Gangliosides [56]. Briefly, cells were grown to
near confluency, washed with PBS and 150 mM NaCl and
were harvested by gentle scraping. 5 × 107 cells were sus-
pended in a total volume of 450 μl of 150 mM NaCl. All
following solvent extraction steps were carried out in a
glass vial. 5 ml of chloroform/methanol (1:1, v/v) was
added. To facilitate extraction of lipids, the suspension
was sonicated for 30 min in a bath sonicator interrupted
by 2 × 5 min of vortexing. Insoluble material was pelleted
by centrifugation at 3200 × g for 10 min and subsequently
subjected to 2 further extraction steps. Three ml of chlo-
roform/methanol (1:1) or chloroform/methanol/H2O
(48:35:10, v/v), respectively, were added and extraction
and centrifugation were performed as before. All 3 super-
natants were collected, dried under nitrogen and redis-
solved in 1.5 ml chloroform/methanol/H2O (40:20:3, v/v).
For the lipid spot binding assay small spots of lipid solu-
tions of about 25 mg/ml in organic solvent were dried on
cover slips. Remaining traces of solvent were removed by
applying vacuum for at least 1 h. The spots were covered
by PBS, which contained fluorescent viral particles. The
concentration of viral particles had been measured by flu-
orescence correlation spectroscopy (FCS) before and
adjusted accordingly. Confocal laser scanning images of
the surface of the lipid spots were obtained on a Zeiss
LSM 510 and evaluated by ImageJ and custom made Perl
scripts. In short, particles were detected and counted in 3
subsequent images after smoothing and intensity thresh-
olding. Diffusing particles that appear blurred due to slow
scanning were discarded based on their low circularity
(sqrt(area)/perimeter < 0.21). For a quality control of the
lipid extract the binding of cholera toxin subunit B and
Annexin V was observed in PBS or PBS containing 2 mM
CaCl2, respectively. The toxin and Annexin V both bound
to the spotted lipid extract but not to synthetic DOPC
and only Annexin V bound to DOPS. This shows that
both charged lipids as phosphatidyl serine (detected by
Annexin V) and highly polar glycolipids like GM1
(detected by cholera toxin) were extracted.
Giant unilamellar vesicles (GUVs) were produced by
electroformation [57]. In short, lipids were dried on
opposed indium tin oxide (ITO) coated coverslips and the
resulting chamber was filled with 465 mM sucrose/2 mM
EDTA. An alternating voltage of 2 V/10 Hz was applied
for 2 h in order for the GUVs to form. These vesicles were
sedimented in double the volume of 1.5 × PBS. Virus par-
ticles were added before observation of binding in confo-
cal microscopy.
Combined Atomic Force Microscopy (AFM) and Confocal 
Fluorescence Microscopy
PFV particles were harvested as described above and
additionally fixed by addition of PFA (paraformaldehyde)
at a final concentration of 2% to the cell culture superna-
tant and to the 20% sucrose cushion prior to ultracentrif-
ugation.
AFM and fluorescence imaging were performed at
room temperature using the same experimental appara-
tus. It consisted of a NanoWizard AFM (JPK Instruments,
Berlin, Germany) mounted on a Laser scanning micro-
scope (LSM) 510 Meta (Zeiss, Jena, Germany). For AFM
imaging, uncoated silicon cantilevers (MikroMasch,
Spain) with typical spring constant of 0.3 N/m (manufac-
turer specified) were used in intermittent contact mode.
The cantilever oscillation was tuned to a frequency of ~5
kHz, with a maximum amplitude set to 0.1- 0.15 V (5-7.5
nm). The scan rate was set to 0.7- 1 Hz. The height, error,
and phase-shift signals were collected simultaneously in
both trace and retrace directions. Images were line-fitted
as required. Isolated scan lines were occasionally
removed. For confocal fluorescence microscopy, the exci-
tation light of an Argon laser at 488 nm was reflected by a
dichroic mirror (HFT 490) and focused onto the sample
by a Zeiss C-Apochromat 40×, NA = 1.2 UV-VIS-IR
water immersion objective. Fluorescence signal was then
recollected by the same objective and, after passing
through a 530/30 bandpass filter, measured by a photo-
multiplier (PMT). The confocal geometry was ensured by
a 70 nm pinhole in front of the PMT.
Precise spatial alignment of fluorescence imaging and
AFM was achieved using 0.1 μm size fluorescent car-
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Probes, Eugene, OR) as "topographical landmarks". Viral
particles and fluorescent beads were mixed in phosphate
buffer (1 mM KCl, 0.5 mM KH2PO4, 2.7 mM Na2HPO4,
50 mM NaCl, pH 7.2) and deposited on a thin fresh
cleaved mica sheet previously treated for 10 minutes with
a 0.1 mg/ml poly-D-lysine (P7280, Sigma) solution. After
ca. 20 minutes, the sample was rinsed with the same
phosphate buffer and then ready for imaging.
CLSM analysis of PFV binding to host cells
Host cells were seeded at a density of 1.5 × 104 cells/well
into 8 well chamber slides. After 24 h cells were cooled
down and incubated on ice with fluorescent PFV particle
preparations for 30 min. Subsequently cells were washed
with cold PBS and either fixed with 3% PFA or incubated
an additional 30 min at 37°C before fixation. After fixa-
tion the cell nuclei were stained with DAPI for 5 min.
Finally the cells were covered with 50% glycerol (in
water). Confocal laser scanning images were obtained on
a Zeiss LSM 510 and evaluated by ImageJ. The excitation
light of an Argon laser at 488 nm or a Diode laser at 405
nm was reflected by a dichroic mirror (HFT 405/488/
561) and focused onto the sample by a Zeiss Apochromat
63×, NA = 1.4 oil immersion objective. Fluorescence sig-
nal was then recollected by the same objective, splitted by
a dichroic mirror (NFT 490) and after passing through
either a 520/30 or 420/60 bandpass filter, measured by a
photomultiplier (PMT). The confocal geometry was
ensured by a 1 Airy Unit pinhole in front of the PMT.
Electron microscopy analysis
At 48 h post transfection, the 293T cells were harvested
and processed for electron microscopy analysis as
described previously [58].
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